Merck Returns Global Marketing and Development Rights for Vernakalant to Cardiome

[at noodls] – VANCOUVER, CANADA and WHITEHOUSE STATION, N.J., SEPTEMBER 26, 2012 — Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced … more

View todays social media effects on CRME

View the latest stocks trending across Twitter. Click to view dashboard